Your browser doesn't support javascript.
loading
Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L).
Miyawaki, Taichi; Kenmotsu, Hirotsugu; Harada, Hideyuki; Ohde, Yasuhisa; Chiba, Yasutaka; Haratani, Koji; Okimoto, Tamio; Sakamoto, Tomohiro; Wakuda, Kazushige; Ito, Kentaro; Uemura, Takehiro; Sakata, Shinya; Kogure, Yoshihito; Nishimura, Yasumasa; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki.
Affiliation
  • Miyawaki T; Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Kenmotsu H; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Harada H; Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan. h.kenmotsu@scchr.jp.
  • Ohde Y; Radiation and Proton Therapy Center, Shizuoka Cancer Center, Shizuoka, Japan.
  • Chiba Y; Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Haratani K; Clinical Research Center, Kindai University Hospital, Osaka-sayama, Japan.
  • Okimoto T; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Japan.
  • Sakamoto T; Department of Internal Medicine, Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
  • Wakuda K; Division of Respiratory Medicine and Rheumatology, Department of Multidisciplinary Internal Medicine, Tottori University, Yonago city, Japan.
  • Ito K; Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Uemura T; Respiratory Centor, Matsusaka Municipal Hospital, Matsusaka, Japan.
  • Sakata S; Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Kogure Y; Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Nishimura Y; Department of Respiratory Medicine, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Nakagawa K; Department of Radiation Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Japan.
  • Yamamoto N; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Japan.
BMC Cancer ; 21(1): 1121, 2021 Oct 18.
Article in En | MEDLINE | ID: mdl-34663250
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Immune Checkpoint Inhibitors / Lung Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Immune Checkpoint Inhibitors / Lung Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Country of publication: